Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Collagen Cross-linking in Eyes With Corneal Thinning Conditions Using Peschke Riboflavin Solution

NCT04177082 is registered in ClinicalTrials.gov with Cornea Associates of Texas as lead sponsor.

NCT NCT04177082
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04177082 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Safety and Effectiveness of the PXL-Platinum 330 System for Corneal Collagen Cross-linking in Eyes With Corneal Thinning Conditions Using Peschke Riboflavin Solution
Lead sponsor
Cornea Associates of Texas
Phase
Phase 1
Overall status
Completed
Start date
January 10, 2020
Completion date
May 5, 2022
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

corneal degeneration, corneal ectasia, keratoconus, pellucid marginal corneal degeneration